newsFDA gives first RMAT designation to a cardiac gene therapy8 February 2023 | By Catherine Eckford (European Pharmaceutical Review)A regenerative medicine advanced therapy (RMAT) designation has been given to a gene therapy for Danon disease by the US Food and Drug Administration (FDA).
